Transmitter release and uptake evoked by the amphibian skin alkaloid, pumiliotoxin-B (PTX-B), in the electrically stimulated mouse vas deferens preparation (MVD)

Journal of Autonomic Pharmacology

Volumn 18, Issue 6, 1998, Pages 333-342

  Severini, C ^a   Falconieri Erspamer, G ^b   Erspamer, Vittorio ^b  

^a CNR   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALKALOID; DESIPRAMINE; GUANETHIDINE; HALOPERIDOL; NEUROPEPTIDE Y; NORADRENALIN; OCTOPAMINE; PRAZOSIN; PROPRANOLOL; PUMILIOTOXIN; SODIUM CHANNEL; TETRODOTOXIN; YOHIMBINE;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ELECTROSTIMULATION; MALE; MUSCLE TWITCH; NEUROTRANSMITTER RELEASE; NEUROTRANSMITTER UPTAKE; NONHUMAN; VAS DEFERENS;

EID: 0032422396     PISSN: 01441795     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2680.1998.1860333.x     Document Type: Article

References (34)

1. ALBUQUERQUE, E.X, WARNICK, J.E., MALEQUE, M.A., KAUFFMAN, F.C., TAMBURINI, R., NIMIT, Y. & DALY, J.W. (1981). The pharmacology of pumiliotoxin B. I. Interaction with calcium sites in the sarcoplasmatic reticulum of skeletal muscle. Mol. Pharmacol., 19, 411-424.
2. AMBACHE, M. & ZAR, M.A. (1971). Evidence against adrenergic motor transmission in the guinea-pig vas deferens. J. Physiol., 216, 359-389.
3. BOLAND, B., HIMPENS, B., VINCENT, M.F., GILLIS, J.M. & CASTEELS, R. (1992). ATP activates P2x-contracting and P2y-relaxing purinoreceptors in the smooth muscle of mouse vas deferens. Br. J. Pharmacol., 107, 1152-1158.
4. BULTMANN, R., VON KUGELGEN, I. & STARKE, K. (1991). Contraction-mediating alpha 2-adrenoreceptors in the mouse vas deferens. Naunyn-Schmiedeberg's Arch. Pharmacol., 343, 623-632.
5. BURNSTOCK, G. (1987). Purinergic nervous system. In: Encyclopedia of Neuroscience, Vol. 2, pp. 1015-1017. Ed. G. Adelman. Birkhäuser, Boston, MA.
6. CARRUTU, M.R., CAMERINO, D.C., DE SERIO, A., FERRARI, E. & MITOLO CHIEPPA, D. (1990). Prejunchonal regulation of sympathetic neurotransmission in the mouse vas deferens: assessment of agonist and antagonist petencies. J. Autonon. Nerv. System, 30, S35-37.
7. DALY, J.W., GARRAFFO, H.M. & SPANDE, T.F. (1992). Amphibian alkaloids. In: The Alkaloids, Vol. 43, pp. 185-288. Ed. G.F. Cordell. Academic Press, San Diego, CA.
8. DRAKE, M.E. & PETERSON, S.A. (1993). ATP overflow from the mouse vas deferens. Br. J. Pharmacol., 105, 825-830.
9. ELLIS, J.L. & BURNSTOCK, G. (1990). Neuropeptide Y neuromodulation of sympathetic co-transmission in the guinea-pig vas deferens. Br. J. Pharmacol., 100, 457-462.
10. ERSPAMER, V., FALCONIERI ERSPAMER, G., MELCHIORRI, P. & MAZZANTI, G. (1985). A potent factor in extracts of the skin of the Australian frog, Pseudophryne coriacea. Apparent facilitation of transmitter release in isolated smooth muscle preparations. Neuropharmacology, 24, 783-792.
11. ERSPAMER, V. (1994). Bioactive secretions of the integument. In: Amphibian Biology, Vol. 1, The Integument, pp. 178-350. Eds. H. Heatwole & G.T. Barthalmus. Surrey Beatty and Sons, Chipping Norton, NSW, Australia.
12. FRIED, G., TERENTIUS, L., HOEKFELT, T. & GOLDSTEIN, M. (1985). Evidence for differential localization of noradrenaline and neuropeptide Y in neuronal storage vesicles isolated from rat seminal vesicles. J. Neurosci., 5, 450-458.
13. GAILLY, F. BOLAND, B., PAQUES, C., HIMPENS, B., CASTEELS, R. & GILLIS. G.M. (1993). Postreceptor pathway of the ATP-induced relaxation in smooth muscle of the mouse vas deferens. Br. J. Pharmacol., 110, 326-330.
14. GUSOVSKY, F., HOLLINGWORTH, F.D. & DALY, J.W. (1986). Regulation of phosphotidyl inositol turnover in brain synaptoneurones: stimulatory effect of agents that enhance influx of sodium ions. Proc. Natl. Acad. Sci. USA, 83, 3003-3007.
15. GUSOVSKY, F., PADGETT, W.L., CREVELING, C.R. & DALY, J.W. (1993). Interaction of pumiliotoxin B with an alkaloid binding domain on the voltage dependent sodium channel. Mol. Pharmacol., 42, 1104-1108.
16. HENDERSON, G. & HUGHES, J. (1976). The effects of morphine on the release of noradrenaline from the mouse vas deferens. Br. J. Pharmacol., 57, 551-557.
17. JENKINS, D.A., MARSHALL, I. & NASMITH, P.A. (1977). An inhibitory role of noradrenaline in the mouse vas deferens. Br. J. Pharmacol., 61, 649-655.
18. JONES, M.E.L. & SPRIGGS, T.L.B. (1975). Noradrenaline and smotor transmission in the vas deferens of the mouse. Br. J. Pharmacol., 53, 323-331.
19. KARUNANITHI, S., LAVIDIS, N.A. & BENNETT, M.R. (1993). Evidence that each nerve varicosity on the surface of the mouse vas deferens secretes ATP. Neurosci. Lett., 161, 157-160.
20. KEASET, I.R. (1992). Location and peptide content of pelvic neuron supplying the muscle and lamina propria of the rat vas deferens. J. Autonomic Nerv. Syst., 10, 1-11.
21. KONG, J.Y., THURESON KLEIN, A.K. & KLEIN, R.L. (1990). Are NPY and enkephalin costored in the same noradrenergic neurons and vesicles? Peptides, 11, 565-575.
22. KURZ, K., VON KUGELGEN, I. & STARKE, K. (1993). Prejunctional modulation of noradrenaline release in mouse and rat vas deferens: contribution of P1 and P2 purinoreceptors. Br. J. Pharmacol., 110, 1465-1472.
23. LUNDBERG, J.M., FRANCO CERECED, A., LACROIX, J.S. & PERNOW, J. (1990). Neuropeptide Y and sympathetic neurotransmission. Ann. N. Y. Acad. Sci., 611, 166-174.
24. MARTIN, P.L., KELLY, M. & CUSACK, N.J. (1993). (.)-2-(N-propyl-N-2-thienylethylamine)-5-hydroxytetralin (N 0923) a selective D2 dopamine receptor agonist demonstrates the presence of D2 dopamine receptor in the mouse vas deferens, but not in the rat vas deferens. J. Pharmacol. Exp. Ther., 267, 1342-1348.
25. MENSAH DWUMAH, M. & DALY, J.W. (1978). Pharmacological activity of alkaloids from poison dart frogs (Dendrobathidae). Toxicon, 16, 189-194.
26. OHHASHI, T. & JACOBOWITZ, D.M. (1983). The effects of pancreatic polypeptide and neuropeptide Y on the rat vas deferens. Peptides, 4, 381-386.
27. RAO, K.S., WARNICK, J.E., DALY, J.W. & ALBUQUERQUE, E.X. (1987). Pharmacology of the alkaloid pumiliotoxin B. Possible involvement of calcium- and sodium-dependent processes in nerve and skeletal muscle. J. Pharmacol. Exp. Ther., 243, 775-783.
28. STARKE, K. (1996). Postganglionär-sympatische Erregungsüher-tragung. DGPT Mitteil, 18, 23-27.
29. STJERNQUIST, M., HÄKANSON, R., LEANDER, S., OWMAN, C., SUNDLER, F. & UDDMAN, R. (1983). Immunohistochemical localization of substance P, vasoactive intestinal polypeptide and gastrin-releasing peptide in vas deferens and seminal vesicles, and the effect of these and other eight neuropeptides on resting tension and neurally evoked contractile activity. Regul. Peptides, 7, 67-86.
30. TATEMOTO, K. (1990). Neuropeptide Y and its receptor antagonists. Ann. N. Y. Acad. Sci., 611, 1-6.
31. TORRES, G., BITRAN, M. & HUIDOBRO-TORO, J.P. (1988). Co-release of neuropeptide Y and noradrenaline from the sympathetic nerve terminals, supplying the rat vas deferens: influence of calcium and the stimulation intensity. Neurosci. Lett., 144, 39-42.
32. VON KUGELGEN, I., KURZ, K. & STARKE, K. (1994). P2-Purinoreceptor mediated autoinhibition of sympathetic transmitter release in mouse and rat vas deferens. Naunyn-Schmiedeberg's Arch. Pharmacol., 349, 125-132.
33. WAHLESTEDT, C., GRUNDEMAR, L., HÄKANSON, R., HEILIG, M., SHEN, G.H., LUKOWSKAGROJEC, Z. & REIS, D.J. (1990). Neuropeptide receptor subtypes, Y1 and Y2. Ann. N. Y. Acad. Sci., 611, 7-26.
34. WITT, P.A., KRAMER, T.H. & BURKS, T.F. (1991). Norepinephrine and ATP are synergistic in the mouse vas deferens preparation. Eur. J. Pharmacol., 204, 149-155.